Nuvasive’s former CEO joins 3M spinoff

Name: Chris Barry

New title: Group president of the Medical Solutions Division for 3M’s health care business group

Previous title: Nuvasive CEO

For the last five years, Barry was CEO of spine specialist Nuvasive, which was acquired in September by orthopedics company Globus Medical. Prior to his time with Nuvasive, Barry also held leadership roles at Medtronic and Covidien.

Barry will join 3M in March, leading its Medical Solutions Division, which includes its wound care products. His responsibilities include driving growth for the division, portfolio management, and product and business model innovation.

Barry is the latest medtech executive to join 3M’s health business as the company prepares for a spinoff. 3M has also poached executives from Zimmer Biomet and Insulet to lead the new company, to be named Solventum.

The company is expected to spin out in the first half of 2024, subject to board approval and other conditions.

Integra to buy J&J’s Acclarent for $275M

Dive Brief: Integra Lifesciences reached an agreement to buy Johnson & Johnson’s ear, nose and throat (ENT) subsidiary Acclarent for $275 million in cash, the

December 13, 2023

Is there an association between psoriasis onset and risk of autoimmune disease?

Researchers evaluated new-onset autoimmune disease risk among individuals with new-onset psoriatic illness.

October 9, 2023

Taking Telemedicine Visits From Your Kitchen? Think Again

Patients preferred professional backgrounds over home environments for telemedicine video visits, a survey-based cross-sectional study showed. Using a 10-point scale, a background showing a physician

May 16, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.